Get the Stockscreener App
2.80
3.45%
-0.1001
After Hours:
2.77
-0.03
-1.07%
Scinai Immunotherapeutics Ltd Adr stock is traded at $2.80, with a volume of 4,626.
It is down -3.45% in the last 24 hours and down -20.83% over the past month.
See More
Previous Close:
$2.9001
Open:
$2.8468
24h Volume:
4,626
Relative Volume:
0.37
Market Cap:
$3.12M
Revenue:
-
Net Income/Loss:
$-9.29M
P/E Ratio:
-0.5385
EPS:
-5.2
Net Cash Flow:
$-9.42M
1W Performance:
-17.65%
1M Performance:
-20.83%
6M Performance:
-23.08%
1Y Performance:
-46.05%
1-Day Range:
$2.80
$2.9488
1-Week Range:
$2.25
$3.92
52-Week Range:
$2.23
$8.92
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Company Profile
Name
Scinai Immunotherapeutics Ltd Adr
Sector
Industry
Phone
972-8-9302529
Address
JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM
Compare SCNI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCNI
Scinai Immunotherapeutics Ltd Adr
|
2.80 | 3.12M | 0 | -9.29M | -9.42M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Latest News
Scinai Immunotherapeutics (NASDAQ: SCNI) Enters $10M Standby Equity Purchase Agreement - Barchart
Scinai Immunotherapeutics Ltd ADR (SCNI) Stock: Evaluating the Annual Growth - The News Heater
Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Announces Strategic Board Appointment - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Welcomes Dr. Jonathan Sadeh to Scientific Advisory Board - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports Nine-Month Financial Results - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) to Spotlight I&I Pipeline, CDMO Services at BIO-Europe 2024 - Barchart
Scinai reports Q1 results, progresses in pipeline By Investing.com - Investing.com South Africa
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Benzinga
Scinai Immunotherapeutics enacts reverse split to meet Nasdaq rules - Investing.com
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):